Clinical Trials Sponsored by ModernaTX, Inc.
Total 35381 results
-
ModernaTX, Inc.RecruitingSARS-CoV-2Korea, Republic of
-
ModernaTX, Inc.RecruitingRespiratory Syncytial VirusCanada, United States, United Kingdom, Puerto Rico
-
ModernaTX, Inc.Recruiting
-
ModernaTX, Inc.RecruitingMethylmalonic AcidemiaUnited States, Spain, Canada, Netherlands, France, Australia, United Kingdom
-
ModernaTX, Inc.Active, not recruitingCytomegalovirus InfectionUnited States, Australia, Canada, France, Belgium, Germany, Israel, Italy, United Kingdom, Spain, Estonia, Finland, Japan
-
ModernaTX, Inc.Active, not recruiting
-
ModernaTX, Inc.CompletedSARS-CoV-2United States
-
ModernaTX, Inc.Active, not recruitingCytomegalovirus | SARS-CoV-2 | Seasonal Influenza | Respiratory Syncytial VirusUnited States
-
ModernaTX, Inc.Active, not recruiting
-
ModernaTX, Inc.Active, not recruitingRespiratory Syncytial VirusUnited States, Panama
-
ModernaTX, Inc.Active, not recruitingRespiratory Syncytial VirusUnited States, Spain, Taiwan, Korea, Republic of, Singapore, Canada, Belgium, Finland, Japan, United Kingdom, Chile, New Zealand, South Africa, Australia, Puerto Rico, Argentina, Costa Rica, Poland, Bangladesh, Colombia, Germany, ... and more
-
ModernaTX, Inc.CompletedSeasonal InfluenzaUnited States
-
ModernaTX, Inc.Active, not recruitingRespiratory Syncytial Virus | Human MetapneumovirusSpain, United Kingdom, Canada, Australia, United States, South Africa, Poland, Colombia, Argentina, Latvia, Panama
-
ModernaTX, Inc.Active, not recruitingA Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy AdultsInfluenza | SARS-CoV-2United States
-
ModernaTX, Inc.Active, not recruiting
-
ModernaTX, Inc.Active, not recruitingInfluenza | SARS-CoV-2United States
-
ModernaTX, Inc.Completed
-
ModernaTX, Inc.Completed
-
ModernaTX, Inc.WithdrawnRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
ModernaTX, Inc.Completed
-
ModernaTX, Inc.Active, not recruitingHerpes ZosterUnited States, Puerto Rico
-
ModernaTX, Inc.Completed
-
ModernaTX, Inc.CompletedSARS-CoV-2United States
-
ModernaTX, Inc.TerminatedOvarian Cancer | Relapsed/Refractory Solid Tumor Malignancies or LymphomaUnited States
-
ModernaTX, Inc.CompletedHuman Metapneumovirus and Human Parainfluenza InfectionUnited States
-
ModernaTX, Inc.RecruitingRespiratory Syncytial VirusCanada, United Kingdom, Japan, United States, Chile, Denmark, Panama, South Africa
-
ModernaTX, Inc.Recruiting
-
ModernaTX, Inc.Recruiting
-
ModernaTX, Inc.Recruiting
-
ModernaTX, Inc.RecruitingMethylmalonic AcidemiaUnited States, Canada, Netherlands, United Kingdom
-
ModernaTX, Inc.RecruitingPropionic AcidemiaUnited States, Canada, United Kingdom
-
ModernaTX, Inc.Active, not recruitingRespiratory Syncytial VirusUnited States
-
ModernaTX, Inc.CompletedPregnancy | Maternal Outcomes | Infant OutcomesUnited States
-
ModernaTX, Inc.Completed
-
ModernaTX, Inc.CompletedInfluenza | SARS-CoV-2United States
-
ModernaTX, Inc.Active, not recruitingSeasonal InfluenzaUnited States
-
ModernaTX, Inc.CompletedSeasonal InfluenzaSpain, United States, Denmark, Poland, United Kingdom, Germany, Canada, Taiwan, Bulgaria, Netherlands, Estonia
-
ModernaTX, Inc.CompletedCytomegalovirus InfectionUnited States
-
ModernaTX, Inc.Active, not recruiting
-
ModernaTX, Inc.Completed
-
ModernaTX, Inc.Completed
-
ModernaTX, Inc.Terminated
-
ModernaTX, Inc.Active, not recruitingZika VirusPuerto Rico, United States
-
ModernaTX, Inc.CompletedSeasonal InfluenzaPhilippines, Australia, Colombia, Argentina, Panama
-
ModernaTX, Inc.CompletedCytomegalovirus InfectionUnited States
-
ModernaTX, Inc.Completed
-
ModernaTX, Inc.Active, not recruitingRespiratory Syncytial VirusUnited States
-
ModernaTX, Inc.CompletedCoronavirus Disease (COVID-19)Japan